Form 4 for ZNTL Zentalis Pharmaceuticals, Inc.
Accepted 2024-05-09 00:00:00 ET · period of report 2024-05-09 · accession 0001725160-24-000111 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-09 | 2024-05-09 | ZNTL | HAUSMAN DIANA | Chief Medical Off | S - Sale | $12.62 | -3,356 | 373.9K | -0.9% | -$42.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-09 | S | D | 3,356 | $12.62 | 373,876 | D | — | — |